Plasma Saa levels tended to increase over time in most treatment groups, likely an effect of aging or inflammation induced by hypercholesterolemia, and tended to increase more in male mice deficient in Ldlr (Fig. 3C and Table 3). This evidence concerns the gene LDLR and familial hypercholesterolemia.